This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: MediPharm Labs Corp.
Has begun production on novel cannabis metered dose inhalers for the EU and the United Kingdom, made to global pharmaceutical standards and distributed by Blackpoint Limited, MediPharm’s exclusive sales and distribution partner in those territories. MediPharm Labs Corp. shares T.LABS are trading up $0.01 at $0.08.
